Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Barei

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|April 23, 2026
<i>Letter:</i> Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World ExperienceFrancesca Barei, Alessandra Chiei Gallo, Martina Zussino, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2026
<i>Letter:</i> Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case SeriesFrancesca Barei, Paolo Calzari, Gianluca Avallone, et al.
International Journal of Dermatology|June 14, 2024
Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patientsGabriele Perego, Italo F Aromolo, Francesca Barei, et al.
Italian Journal of Dermatology and Venereology|July 1, 2024
Solitary sclerotic fibroma: a skin-colored, translucent papule with arborizing vessels resembling a basal cell carcinomaMaria A Mattioli, Francesca Boggio, Francesca Barei, et al.
Journal of Clinical Medicine|August 10, 2024
Does Body Mass Index Impact the Clinical Response to Dupilumab Therapy in Atopic Dermatitis? A Monocentric Study of 170 PatientsSelene Nicolosi, Francesca Barei, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology|October 10, 2024
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitisAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
The Australasian Journal of Dermatology|July 25, 2022
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitorsCristina B Spigariolo, Francesca Barei, Carlo A Maronese, et al.
International Journal of Dermatology|October 13, 2024
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life studyAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
The Journal of Dermatological Treatment|November 20, 2023
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experienceSilvia Ferrucci, Francesca Barei, Simona Tavecchio, et al.
International Journal of Dermatology|July 28, 2025
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular EczemaFrancesca Barei, Alessandra Chiei Gallo, Roberto Pinto, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Dermatitis : Contact, Atopic, Occupational, Drug|April 23, 2026
<i>Letter:</i> Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World ExperienceFrancesca Barei, Alessandra Chiei Gallo, Martina Zussino, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2026
<i>Letter:</i> Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case SeriesFrancesca Barei, Paolo Calzari, Gianluca Avallone, et al.
International Journal of Dermatology|June 14, 2024
Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patientsGabriele Perego, Italo F Aromolo, Francesca Barei, et al.
Italian Journal of Dermatology and Venereology|July 1, 2024
Solitary sclerotic fibroma: a skin-colored, translucent papule with arborizing vessels resembling a basal cell carcinomaMaria A Mattioli, Francesca Boggio, Francesca Barei, et al.
Journal of Clinical Medicine|August 10, 2024
Does Body Mass Index Impact the Clinical Response to Dupilumab Therapy in Atopic Dermatitis? A Monocentric Study of 170 PatientsSelene Nicolosi, Francesca Barei, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology|October 10, 2024
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitisAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
The Australasian Journal of Dermatology|July 25, 2022
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitorsCristina B Spigariolo, Francesca Barei, Carlo A Maronese, et al.
International Journal of Dermatology|October 13, 2024
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life studyAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
The Journal of Dermatological Treatment|November 20, 2023
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experienceSilvia Ferrucci, Francesca Barei, Simona Tavecchio, et al.
International Journal of Dermatology|July 28, 2025
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular EczemaFrancesca Barei, Alessandra Chiei Gallo, Roberto Pinto, et al.
Pageof 6